Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
: , ,
We treat the root cause or causes of the symptoms instead of merely trying to make the symptoms go away
Deucravacitinib, a tyrosine kinase 2 inhibitor, in systemic lupus erythematosus: a phase II, randomized, double-blind, placebo-controlled trial
For example, a randomized, double-blind, placebo-controlled trial in patients with overweight or obesity -associated KOA assessed the effects of liraglutide (3 mg/day) over 52 weeks as an add-on to dietary guidance [47, 48]
US$ 24.11
US$ 20.18
US$ 21.92
US$ 22.36
US$ 27.32
US$ 26.22
